EPCAM and breast cancer: Limitation of EpCAM-based positive enrichment due to phenotypic heterogeneity of CTCs and variability in EpCAM expression, three breast cancer cell lines with differing EpCAM expressions—MDA-MB-231, MDA-MB-453, and MDA-MB-468—were selected.